Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

3.

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.

Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA.

Trials. 2010 Aug 12;11:85. doi: 10.1186/1745-6215-11-85.

4.

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.

Sun X, Briel M, Walter SD, Guyatt GH.

BMJ. 2010 Mar 30;340:c117. doi: 10.1136/bmj.c117. No abstract available.

PMID:
20354011
5.

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group..

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473.

6.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group..

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646.

7.

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251.

8.

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group..

Am J Cardiol. 2007 Dec 1;100(11):1659-64.

9.

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Kent DM, Hayward RA.

JAMA. 2007 Sep 12;298(10):1209-12. No abstract available.

PMID:
17848656
10.
11.

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Ridker PM, Buring JE, Rifai N, Cook NR.

JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.

PMID:
17299196
12.

Decision curve analysis: a novel method for evaluating prediction models.

Vickers AJ, Elkin EB.

Med Decis Making. 2006 Nov-Dec;26(6):565-74.

13.

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis.

Hayward RA, Kent DM, Vijan S, Hofer TP.

BMC Med Res Methodol. 2006 Apr 13;6:18.

14.

Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.

Steyerberg EW, Homs MY, Stokvis A, Essink-Bot ML, Siersema PD; SIREC Study Group..

Gastrointest Endosc. 2005 Sep;62(3):333-40.

PMID:
16111947
15.

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Kravitz RL, Duan N, Braslow J.

Milbank Q. 2004;82(4):661-87. Erratum in: Milbank Q. 2006;84(4):759-60.

16.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.

J Clin Oncol. 2004 May 15;22(10):1797-806.

PMID:
15067028
18.
20.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults..

JAMA. 2001 May 16;285(19):2486-97. No abstract available.

PMID:
11368702
Items per page

Supplemental Content

Support Center